The global catheter market size was estimated at USD 54.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.57% from 2024 to 2030. The increasing cases of chronic disorders such as neurological, cardiovascular, and urological disorders requiring hospitalization boosts the expansion of the market. For instance, as per the reports published by the National Library of Medicine in 2023, approximately 15% of the global population suffers from neurological disorders, which cause physical and cognitive disabilities.
According to the WHO, over 200 million individuals worldwide are affected by various urological disorders. In the U.S., urological disorders impact nearly 25 million people, with women constituting 80% of this population. With the increasing prevalence of conditions such as urinary retention, UI, benign prostatic hyperplasia, and neurogenic bladder dysfunction, there has been a growing demand for catheterization for short-term or long-term management of these ailments. Furthermore, the market is anticipated to experience growth in the forecast period due to a surge in midscale catheter manufacturers competing for a larger market share.
Major market players use advanced materials, such as polyurethanes/polycarbonates, to manufacture catheters. Carbothane, resistant to chemicals such as iodine, hydrogen peroxide, or alcohol is used to make catheters to increase their longevity. For instance, MAHURKAR Chronic Carbothane catheter, manufactured by Medtronic, is easy to insert with a single technique and ensuring top-notch resistance to kinks. This catheter provides impressive flow rates with minimal pressure on both arterial and venous systems.
Moreover, catheters made of Durathane offer resistance and strength. For example, the DuraFlow 2 chronic hemodialysis catheter, offered by AngioDynamics, is made of Durathane, which offers advantages of both silicone and polyurethane. This catheter material offers strength and is resistant to a variety of commonly used site care agents. Thus, the use of advanced materials to manufacture catheters is increasing their demand among end users.
The increasing awareness of controlling catheter-related bloodstream infections (CRBSI) among the people will contribute to a greater demand for catheters in the coming forecast period. A significant factor leading to catheter-related bloodstream infections (CRBSI) is the lack of proper care and maintenance for these devices. Healthcare professionals are preferring the use of catheters that pose minimal infection risks due to their increased awareness and emphasis on infection control. For instance, in May 2023, BD introduced a convenient prefilled flush syringe for customers. This innovative BD PosiFlush SafeScrub syringe is designed to enhance patient care by expediting the flushing and disinfection of IV catheters during clinical procedures. Ensuring the cleanliness and disinfection of catheters is crucial in preventing CRBSIs. As a result, healthcare professionals are becoming more aware of the significance outlined in infection prevention guidelines, enhancing the need for the proper flushing, and disinfecting of catheters.
Moreover, treatment of Peripheral Artery Disease (PAD) is usually followed by a minimally invasive procedure that involves the use of catheters to clear the blocked arteries. Growing preference for angioplasty over conventional surgeries has resulted in a rise in the demand for this procedure among patients. As peripheral angioplasty is a minimally invasive procedure and offers better outcomes, it has gained significant popularity over the past decade. The growing demand for minimally invasive procedures can also be attributed to the recent technological innovations, for instance, use of antimicrobial coating and miniaturized catheters to prevent the risk of restenosis. These procedures have higher adoption rates and are becoming standard techniques in general surgery due to the use of advanced technologies and innovative coated catheters available in the market. Thus, the growing preference for minimally invasive surgeries is expected to drive the growth of the catheters market during the forecast period.
The market growth stage is moderate, and pace of the market growth is accelerating. The catheter market is characterized by a moderate-to-high degree of growth owing to increasing investment in R&D programs, prevalence of conditions such as urinary incontinence, cardiovascular diseases, and neurovascular disorders has led to a rise in the usage of catheters. Furthermore, the growing recognition among both healthcare professionals and patients regarding the advantages of catheterization in the treatment of diverse medical conditions is contributing significantly to the expansion of the market.
Key strategies implemented by players in the market are new product launches, regulatory approval, acquisitions, partnerships, and other strategies. For instance, in January 2024, Cook Medical's Tip Hydrophilic Selective catheter, the Slip-Cath Beacon, was made available for use in both the Canada and U.S. This hydrophilic angiographic catheter is specifically designed to cater to a broad spectrum of vascular and non-vascular procedures. It is used during angiographic procedures, working in tandem with vascular access sheaths, wire guides, and various treatment devices.
The development of bioresorbable, biocompatible, and drug-eluting materials for catheters is enabling minimally invasive procedures with improved outcomes and reduced complications influencing the market growth. Companies are investing highly in advanced technologies and effectively utilizing these technologies often gain a competitive edge, driving market growth. Such advancements and innovations in catheters drive market growth.
Mergers and acquisition activities in the market are increasing and witness similar growth during the analysis timeframe. Several companies are acquiring development-stage companies to enhance the company’s product portfolio to cater to a large patient pool. Moreover, these firms are integrating advanced facilities and form strategic alliances to achieve synergies in capabilities and resources, enhancing their competitiveness.
Stringent quality protocols and regulatory norms by several nations to ensure patient safety and data integrity, which highly impact operational capabilities in the market. For the medical device industry, regulations are crucial for ensuring the effectiveness and safety of devices. Medical device manufacturers are bound by stringent quality and safety regulations imposed by regulatory agencies like the European Medicines Agency and the U.S. FDA. For manufacturers to receive regulatory clearance for their intravenous catheters, they must comply with certain guidelines. Thus, the increasing regulatory approval enhances the product portfolio of the market key players with the novel product launch.
North America holds the largest market share, owing to factors such as a widespread awareness of minimally invasive procedures, and a significant aging population. Moreover, the dominance of the region is reinforced by the presence of leading catheter manufacturers in the U.S.
The market comprises a large number of medical device manufacturers specialized in catheter manufacturing leads to a highly fragmented market scenario.
The heightened recognition of healthcare concerns and the enhanced accessibility to medical services across different areas are driving a surge in the demand for medical devices, such as catheters. With the advancement of healthcare infrastructure, the availability and utilization of catheters are also on the rise in developing countries.
Cardiovascular catheter segment led the market and accounted for 27.99% of the total revenue share in 2023. Rising prevalence of cardiovascular disorders and increasing demand for interventional cardiac procedures, coupled with growing adoption of cardiac catheters, are expected to boost the growth of the market for cardiovascular catheters during the forecast period. For instance, according to data released by the American College of Cardiology in July 2023, around 200 million individuals globally, and over 12 million people in the U.S., are dealing with peripheral artery disease (PAD). The increasing demand for these catheters can be attributed to the increasing incidence of cardiac conditions such as coronary artery disease, congenital heart problems, and cardiac arrhythmia. As the occurrence of these conditions rises, there is an increased need for diagnostic and interventional procedures, with cardiovascular catheters playing a pivotal role in performing minimal invasive procedures.
Specialty catheters segment is projected to witness the highest growth rate over the forecast period owing to the increasing demand for minimally invasive procedures, coupled with rising prevalence of target diseases, Moreover, increasing regulatory approvals are likely to contribute to segment growth. For instance, in February 2022, Teleflex Incorporated received U.S. FDA approval for its specialty catheters used for crossing Chronic Total Occlusion (CTO) that occur during Percutaneous Coronary Intervention (PCI). Specialty catheters are equipped with features such as smoother surfaces, reduced friction, and materials that minimize irritation. This customization enhances patient satisfaction and compliance, particularly in cases where long-term catheterization is necessary.
Hospital stores segment dominated the market with the largest revenue share in 2023. Hospital stores are situated in the hospital premises where it store and dispense a wide range of catheters required for surgical and minimally invasive procedures. Unlike regular pharmacies catering to outpatients, hospital stores prioritize the needs of patients admitted to the hospital. These cater to specific and often rare medical conditions, requiring precise storage and handling protocols.
Moreover, due to the critical nature of their function, hospital stores operate under strict regulations. These regulations govern everything from storage conditions and dispensing procedures to personnel qualifications and record-keeping practices. This stringent framework ensures patient safety and medication accuracy. Additionally, modern hospital stores leverage cutting-edge technology to streamline operations and optimize medication management. Automated dispensing systems, electronic prescribing platforms, and advanced inventory tracking software are just a few examples. These technologies minimize errors, improve efficiency, and enhance patient care. Time is often of the essence in healthcare, and hospital stores ensure immediate access to the needed catheters. This reduces delays in treatment and potentially improves patient outcomes. These factors boost the demand for catheters in the hospital stores, driving the market growth.
The retail stores segment is projected to witness the highest growth rate over the forecast period. This is attributed to the availability of various e-commerce platforms which sell catheters. These platforms offer convenient, choice-filled, and often cost-effective way to purchase the catheters. For instance, the e-commerce sites that offer warranty, discounts, and prompt customer service for catheters are Shopcatheters, Allegro Medical Supplies Inc., and Amazon. This has a positive impact on the sales of the products through these sales channels. Thus, supporting the segment growth during the forecast period.
North America accounted for 31.72% of the global market in 2023 and is expected to continue its dominance over the forecast period. This can be ascribed to various factors, including the growing incidence of chronic illnesses and an aging population, as well as the favorable impact of major manufacturers like Teleflex Incorporated, Medtronic, and Boston Scientific Corporation enhancing regional growth. The market for catheters in North America has expanded due to favorable government regulations, rising public awareness, a large number of highly competent health care providers, and the presence of prominent healthcare facilities.
The demand for catheters may be positively impacted by greater patient and healthcare community understanding of the importance of early identification and treatment for chronic illnesses. The Centers for Medicare & Medicaid Services (CMS), for instance, predicted that in 2022, health spending in the U.S. will be 7.5% of GDP. It was predicted to cross $1 trillion in 2023. In addition, high disposable income in developed economies & skilled professionals are some factors responsible for the large share of the market of the country.
Asia Pacific region is anticipated to grow at the fastest CAGR over the forecast period. This can be attributed to the presence of large population suffering from kidney & cardiovascular diseases, improvement in medical facilities, and availability of insurance policies. Increased surgical volume, growing government partnerships, and a developing medical device portfolio all contribute to regional growth. Additionally, an increase in government initiatives contributes to market developments in the region.
For instance, in July 2022, the Asia Pacific Society of Infection Control introduced the APSIC guide on the prevention of catheter-linked UI infections. The program focuses on offering practical recommendations provided in a brief format to help healthcare facilities in Asia Pacific maintain high standards of infection prevention & management. Its primary objective was to guide the management and care of patients with a urinary catheter. Moreover, the presence of a large patient pool and the growing need for technologically advanced & cost-efficient healthcare solutions are expected to present significant regional growth opportunities in the market.
Indian market is anticipated to grow at a CAGR of 7.7% over the forecast period. The key factors estimated to drive the Indian market are adoption of new technology in catheter manufacturing, growing disease variation and prevalence, and increasing research and development for enhancing the product portfolio.
The catheters market is experiencing several noteworthy trends that are significantly impacting the activities of top players in the industry. Technological advancements play a pivotal role, with ongoing innovations in catheter design, materials, and technologies enhancing the capabilities of these medical devices. Minimally invasive procedures, improved patient outcomes, and reduced recovery times are driving increased demand for catheters across various medical specialties.
The rising prevalence of chronic diseases, coupled with a growing aging population, is influencing market dynamics. As a result, top players in the catheters industry are expanding their product portfolios to address the diverse needs of patients requiring cardiovascular, urological, and neurovascular interventions. Companies are focusing on the development of catheters that are not only effective but also user-friendly, catering to the increasing demand for patient-centric healthcare solutions. In addition, increasing adoption of catheters in home healthcare services is another major factor driving the growth of the market. Patients are now receiving catheter-related treatments at home, prompting top players to explore new business models and service offerings to support this shift. The emphasis on home healthcare is reshaping the market landscape and challenging companies to provide solutions that meet the evolving needs of both healthcare professionals and patients.
The following are the leading companies in the catheter market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these catheter companies are analyzed to map the supply network.
In October 2023, B. Braun introduced the Introcan Safety 2 IV Catheter, featuring multi-access blood control, designed to ensure the protection of clinicians each time the hub is accessed
In October 2023, the Orchid SRV safety released valves was approved by the U.S. FDA, according to Linear Health Sciences. The purpose of the catheter, which had been authorized to be employed with all IV access procedures, was to reduce the likelihood of IV catheter rupture and repair in hospitals
In February 2023, Teleflex Incorporated declared that the U.S. FDA had granted its Triumph Catheter's 510(k) clearance. This innovative device features clear visualization and exact wire progression. Furthermore, the business reported that the UW Medicine Heart Institute in Seattle, Washington, witnessed the first clinical use of its GuideLiner Coast Catheter
In December 2022, Boston Scientific declared the goal to acquire a controlling position in Acotec Scientific Holdings Limited, a Chinese medical technology business, through a strategic investment. In addition to thrombus aspiration catheters and radiofrequency ablation technologies, the company is highly renowned in China for its drug-coated balloons (DCBs). With this transaction, Boston Scientific intended to improve its position in this region
In February 2022, Medtronic declared that the FDA had approved the use of its Freezor Xtra Cardiac Cryoablation and Freezor and Focal Catheters for the treatment of juvenile Atrioventricular Nodal Reentrant Tachycardia (AVNRT). The catheters are single-use, flexible devices that help treat the problem by freezing cardiac tissue and obstructing any unwanted electrical signals within the heart
Report Attribute |
Details |
Market size value in 2024 |
USD 58.16 billion |
Revenue forecast in 2030 |
USD 85.19 billion |
Growth Rate |
CAGR of 6.57% from 2024 to 2030 |
Actual data |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Report Updated |
February 2024 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends, and volume analysis |
Segments covered |
Product type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country Scope |
U.S.; Canada; UK; Germany; Italy; France; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Hollister Incorporated; Medtronic; Boston Scientific Corporation; Edward Lifesciences; Smith Medical Inc.; Teleflex Incorporated; ConvaTec Group Plc |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global catheter market report based on product type, end use, and region.
Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular Catheters
Electrophysiology Catheters
PTCA Balloon Catheters
IVUS Catheters
PTA Balloon Catheters
Urology Catheters
Hemodialysis Catheters
Peritoneal Catheters
Foley Catheters
Intermittent Catheters
External Catheters
Intravenous Catheters
Peripheral Catheters
Midline Peripheral Catheters
Central Venous Catheters
Neurovascular Catheters
Specialty Catheters
Wound/Surgical Catheters
Oximetry Catheters
Thermodilution Catheters
IUI Catheters
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital Stores
Retail Stores
Others
Region Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global catheter market size was estimated at USD 54.68 billion in 2023 and is expected to reach USD 58.16 billion in 2024.
b. The global catheter market is expected to grow at a compound annual growth rate of 6.57% from 2024 to 2030 to reach USD 85.19 billion by 2030.
b. North America dominated the catheter market with a share of 31.72% in 2023. This is attributable to the presence of multinational manufacturers and sophisticated healthcare infrastructure along with high product awareness levels.
b. Some of the key players operating in the catheter market include Hollister Incorporated, Medtronic, Boston Scientific Corporation, Edward Lifesciences, Smith Medical Inc., Teleflex Incorporated, ConvaTec Group Plc.
b. Key factors that are driving the market growth include rising demand for antimicrobial catheters, increasing prevalence of cardiovascular, neurology, and urology disorders, and growing usage of advanced materials in the catheters.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Catheter Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Increasing number of clinical trials
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing Incidence of Chronic Disorders
3.3.1.2. Increasing Awareness of Controlling Catheter-Related Bloodstream Infections (CRBSI)
3.3.1.3. Growing Use of Advanced Materials in Catheters
3.3.2. Market Restraint Analysis
3.3.2.1. Stringent Regulations for Novel Product Launch
3.3.2.2. Risk and Complications Associated with the Catheters
3.3.3. Market Opportunities Analysis
3.3.3.1. Growing Preference for Minimally Invasive Procedures
3.3.4. Market Challenge Analysis
3.3.4.1. High Cost of Products
3.4. Catheter Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Bargaining power of suppliers
3.4.1.2. Bargaining power of buyers
3.4.1.3. Threat of substitutes
3.4.1.4. Threat of new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political & Legal Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological landscape
Chapter 4. Catheter Market: Product Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Catheter Market: Product Type Movement Analysis & Market Share, 2023 & 2030
4.3. Cardiovascular Catheters
4.3.1. Cardiovascular Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.1. Electrophysiology Catheters
4.3.1.1.1. Electrophysiology Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.2. PTCA Balloon Catheters
4.3.1.2.1. PTCA Balloon Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.3. IVUS Catheters
4.3.1.3.1. IVUS Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.4. PTA Balloon Catheters
4.3.1.4.1. PTA Balloon Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Urology Catheters
4.4.1. Urology Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.1.1. Hemodialysis Catheters
4.4.1.1.1. Hemodialysis Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.1.2. Peritoneal Catheters
4.4.1.2.1. Peritoneal Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.1.3. Foley Catheters
4.4.1.3.1. Foley Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.1.4. Intermittent Catheters
4.4.1.4.1. Intermittent Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.1.5. External Catheters
4.4.1.5.1. External Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Intravenous Catheters
4.5.1. Intravenous Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.1. Peripheral Catheters
4.5.1.1.1. Peripheral Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.2. Midline Peripheral Catheters
4.5.1.2.1. Midline Peripheral Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.1.3. Central Venous Catheters
4.5.1.3.1. Central Venous Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Neurovascular Catheters
4.6.1. Neurovascular Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Specialty Catheters
4.7.1. Specialty Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.1.1. Wound/Surgical Catheters
4.7.1.1.1. Wound/Surgical Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.1.2. Oximetry Catheters
4.7.1.2.1. Oximetry Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.1.3. Thermodilution Catheters
4.7.1.3.1. Thermodilution Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.1.4. IUI Catheters
4.7.1.4.1. IUI Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Catheter Market: End-Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Catheter Market: End-Use Movement Analysis & Market Share, 2023 & 2030
5.3. Hospital Stores
5.3.1. Hospital Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Retail Stores
5.4.1. Retail Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Catheter Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Catheter Market: Regional Movement Analysis & Market Share, 2023 & 2030
6.3. North America
6.3.1. North America Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Scenario
6.3.2.4. Reimbursement Scenario
6.3.2.5. U.S. Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Scenario
6.3.3.4. Reimbursement Scenario
6.3.3.5. Canada Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Europe Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Scenario
6.4.2.4. Reimbursement Scenario
6.4.2.5. UK Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Scenario
6.4.3.4. Reimbursement Scenario
6.4.3.5. Germany Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Scenario
6.4.4.4. Reimbursement Scenario
6.4.4.5. France Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Scenario
6.4.5.4. Reimbursement Scenario
6.4.5.5. Italy Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Scenario
6.4.6.4. Reimbursement Scenario
6.4.6.5. Spain Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Scenario
6.4.7.4. Reimbursement Scenario
6.4.7.5. Denmark Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Scenario
6.4.8.4. Reimbursement Scenario
6.4.8.5. Sweden Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Scenario
6.4.9.4. Reimbursement Scenario
6.4.9.5. Norway Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Scenario
6.5.2.4. Reimbursement Scenario
6.5.2.5. Japan Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Scenario
6.5.3.4. Reimbursement Scenario
6.5.3.5. China Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Scenario
6.5.4.4. Reimbursement Scenario
6.5.4.5. India Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Scenario
6.5.5.4. Reimbursement Scenario
6.5.5.5. South Korea Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Australia
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Scenario
6.5.6.4. Reimbursement Scenario
6.5.6.5. Australia Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Thailand
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Scenario
6.5.7.4. Reimbursement Scenario
6.5.7.5. Thailand Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Scenario
6.6.2.4. Reimbursement Scenario
6.6.2.5. Brazil Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Mexico
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Scenario
6.6.3.4. Reimbursement Scenario
6.6.3.5. Mexico Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. Argentina
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Scenario
6.6.4.4. Reimbursement Scenario
6.6.4.5. Argentina Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Middle East & Africa
6.7.1. Middle East & Africa Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Scenario
6.7.2.4. Reimbursement Scenario
6.7.2.5. South Africa Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Scenario
6.7.3.4. Reimbursement Scenario
6.7.3.5. Saudi Arabia Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Scenario
6.7.4.4. Reimbursement Scenario
6.7.4.5. UAE Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Scenario
6.7.5.4. Reimbursement Scenario
6.7.5.5. Kuwait Catheter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Boston Scientific Corporation
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Service Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. Teleflex Incorporated
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Service Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Medtronic
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Service Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Hollister Incorporated
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Service Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Edward Lifesciences
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Service Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Smith Medical Inc.
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Service Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. ConvaTec Group Plc
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Service Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Cure Medical LLC
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Service Benchmarking
7.2.8.4. Strategic Initiatives
7.3. Heat Map Analysis/ Company Market Position Analysis
7.4. Estimated Company Market Share Analysis, 2022
7.5. List of Other Key Market Players
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 4. Global Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 5. Global Catheter Market, by Region, 2018 - 2030 (USD Million)
Table 6. North America Catheter Market, by Country, 2018 - 2030 (USD Million)
Table 7. North America Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 8. North America Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 9. U.S. Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 10. U.S. Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 11. Canada Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 12. Canada Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 13. Europe Catheter Market, by Country, 2018 - 2030 (USD Million)
Table 14. Europe Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 15. Europe Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 16. Germany Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 17. Germany Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 18. UK Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 19. UK Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 20. France Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 21. France Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 22. Italy Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 23. Italy Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 24. Spain Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 25. Spain Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 26. Denmark Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 27. Denmark Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 28. Sweden Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 29. Sweden Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 30. Norway Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 31. Norway Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 32. Asia Pacific Catheter Market, by Country, 2018 - 2030 (USD Million)
Table 33. Asia Pacific Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 34. Asia Pacific Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 35. China Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 36. China Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 37. Japan Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 38. Japan Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 39. India Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 40. India Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 41. South Korea Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 42. South Korea Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 43. Australia Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 44. Australia Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 45. Thailand Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 46. Thailand Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 47. Latin America Catheter Market, by Country, 2018 - 2030 (USD Million)
Table 48. Latin America Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 49. Latin America Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 50. Brazil Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 51. Brazil Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 52. Mexico Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 53. Mexico Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 54. Argentina Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 55. Argentina Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa Catheter Market, by Country, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 59. South Africa Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 60. South Africa Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 63. UAE Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 64. UAE Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 65. Kuwait Catheter Market, by Product Type, 2018 - 2030 (USD Million)
Table 66. Kuwait Catheter Market, by End - Use, 2018 - 2030 (USD Million)
Table 67. Participant’s Overview
Table 68. Financial Performance
Table 69. Service Benchmarking
Table 70. Strategic Initiatives
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain - Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Catheter Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Catheter Market, for Cardiovascular Catheters, 2018 - 2030 (USD Million)
Fig. 15 Global Catheter Market, for Electrophysiology Catheters, 2018 - 2030 (USD Million)
Fig. 16 Global Catheter Market, for PTCA Balloon Catheters, 2018 - 2030 (USD Million)
Fig. 17 Global Catheter Market, for IVUS Catheters, 2018 - 2030 (USD Million)
Fig. 18 Global Catheter Market, for PTA Balloon Catheters, 2018 - 2030 (USD Million)
Fig. 19 Global Catheter Market, for Urology Catheters, 2018 - 2030 (USD Million)
Fig. 20 Global Catheter Market, for Hemodialysis Catheters, 2018 - 2030 (USD Million)
Fig. 21 Global Catheter Market, for Peritoneal Catheters, 2018 - 2030 (USD Million)
Fig. 22 Global Catheter Market, for Foley Catheters, 2018 - 2030 (USD Million)
Fig. 23 Global Catheter Market, for Intermittent Catheters, 2018 - 2030 (USD Million)
Fig. 24 Global Catheter Market, for External Catheters, 2018 - 2030 (USD Million)
Fig. 25 Global Catheter Market, for Intravenous Catheters, 2018 - 2030 (USD Million)
Fig. 26 Global Catheter Market, for Peripheral Catheters, 2018 - 2030 (USD Million)
Fig. 27 Global Catheter Market, for Midline Peripheral Catheters, 2018 - 2030 (USD Million)
Fig. 28 Global Catheter Market, for Central Venous Catheters, 2018 - 2030 (USD Million)
Fig. 29 Global Catheter Market, for Neurovascular Catheters, 2018 - 2030 (USD Million)
Fig. 30 Global Catheter Market, for Specialty Catheters, 2018 - 2030 (USD Million)
Fig. 31 Global Catheter Market, for Wound/Surgical Catheters, 2018 - 2030 (USD Million)
Fig. 32 Global Catheter Market, for Oximetry Catheters, 2018 - 2030 (USD Million)
Fig. 33 Global Catheter Market, for Thermodilution Catheters, 2018 - 2030 (USD Million)
Fig. 34 Global Catheter Market, for IUI Catheters, 2018 - 2030 (USD Million)
Fig. 35 Global Catheter Market, for Hospital Stores, 2018 - 2030 (USD Million)
Fig. 36 Global Catheter Market, for Retail Stores, 2018 - 2030 (USD Million)
Fig. 37 Global Catheter Market, for Others, 2018 - 2030 (USD Million)
Fig. 38 Regional Outlook, 2021 & 2030
Fig. 39 North America Catheter Market, 2018 - 2030 (USD Million)
Fig. 40 U.S. Catheter Market, 2018 - 2030 (USD Million)
Fig. 41 Canada Catheter Market, 2018 - 2030 (USD Million)
Fig. 42 Europe Catheter Market, 2018 - 2030 (USD Million)
Fig. 43 Germany Catheter Market, 2018 - 2030 (USD Million)
Fig. 44 UK Catheter Market, 2018 - 2030 (USD Million)
Fig. 45 France Catheter Market, 2018 - 2030 (USD Million)
Fig. 46 Italy Catheter Market, 2018 - 2030 (USD Million)
Fig. 47 Spain Catheter Market, 2018 - 2030 (USD Million)
Fig. 48 Denmark Catheter Market, 2018 - 2030 (USD Million)
Fig. 49 Sweden Catheter Market, 2018 - 2030 (USD Million)
Fig. 50 Norway Catheter Market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific Catheter Market, 2018 - 2030 (USD Million)
Fig. 52 Japan Catheter Market, 2018 - 2030 (USD Million)
Fig. 53 China Catheter Market, 2018 - 2030 (USD Million)
Fig. 54 India Catheter Market, 2018 - 2030 (USD Million)
Fig. 55 Australia Catheter Market, 2018 - 2030 (USD Million)
Fig. 56 South Korea Catheter Market, 2018 - 2030 (USD Million)
Fig. 57 Thailand Catheter Market, 2018 - 2030 (USD Million)
Fig. 58 Latin America Catheter Market, 2018 - 2030 (USD Million)
Fig. 59 Brazil Catheter Market, 2018 - 2030 (USD Million)
Fig. 60 Mexico Catheter Market, 2018 - 2030 (USD Million)
Fig. 61 Argentina Catheter Market, 2018 - 2030 (USD Million)
Fig. 62 Middle East and Africa Catheter Market, 2018 - 2030 (USD Million)
Fig. 63 South Africa Catheter Market, 2018 - 2030 (USD Million)
Fig. 64 Saudi Arabia Catheter Market, 2018 - 2030 (USD Million)
Fig. 65 UAE Catheter Market, 2018 - 2030 (USD Million)
Fig. 66 Kuwait Catheter Market, 2018 - 2030 (USD Million)
Market Segmentation
Patients who undergo elective operations under general anesthesia require catheterization. Repeated use of catheters can lead to Catheter-associated Urinary Tract Infections (CAUTIs) and Central line-associated bloodstream infections (CLABSIs). Patients suffering from chronic disorders usually have weak immune systems and require frequent hospitalization. They are at a high risk of infection due to the frequent use of catheters to access the blood vessels. Therefore, companies are increasingly focusing on introducing antimicrobial catheters to reduce the incidence of catheter-associated infections and thrombosis. Palindrome his-heparin coated & silver ion antimicrobial catheters by Medtronic are among the notable antimicrobial catheters available in the market. The heparin coating and silver ion sleeve help reduce the likelihood of clot formation and microbial colonization on the catheters’ surface. In addition, catheters are coated with silver ions or antibiotics (mupirocin or povidone-iodine), using antibiotic ointment at the exit site or antimicrobial solution. Similarly, to reduce the incidence of CLABSIs, Teleflex introduced ARROW acute hemodialysis catheters based on ARROWg+ard Antimicrobial Technology, known for its broad spectrum of antimicrobial protection.
Cardiovascular, urologic, and neurologic diseases are among the major causes of mortality and morbidity in the world over the past three decades. People with a sedentary lifestyle are more susceptible to conditions such as diabetes, Cardiovascular Disorders (CVDs), urologic disorders (including ESRD), and other chronic conditions. High blood pressure & diabetes are the two prime factors contributing to the increasing prevalence of chronic disorders, such as kidney failures. Most kidney disorders are due to conditions such as urinary infections, glomerulonephritis, polycystic kidney problems, lupus, and other malformations. ESRD is more prevalent in people aged 70 years & above. Negative lifestyle habits, such as lack of physical activity & high consumption of alcohol, coupled with rising cases of obesity due to dietary irregularities and growing number of smokers, are a few factors that can cause cardiovascular & neurovascular diseases. With the increasing prevalence of these diseases, the use of catheters is likely to grow.
Catheters are associated with vein thrombosis, which may lead to pulmonary embolism and, in some cases, can be life-threatening. Thrombosis can lead to catheter occlusions, including a mural, venous, or intraluminal thrombosis and/or a fibrin sheath around the catheter tip. Repeated use of catheters has led to an increase in the incidence of Catheter-related Bloodstream Infection (CABSI) and associated complications & risks in patients who underwent catheter insertions. A urinary catheter is an elongated tube inserted into the bladder to drain the urine. Prolonged use of urinary catheters is one of the most common causes of CAUTIs. Malfunction of a dialysis catheter may lead to infections, kinking, and clotting. In some cases, it might also result in the admixing of blood from the catheter. Other adverse effects associated with dialysis include peritonitis, hernia, itching, weight gain, fluid drainage, and bone diseases. The onset of peritonitis is caused by microbial invasion of the peritoneal cavity through dialysis catheter.
This section will provide insights into the contents included in this catheter market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
Company overview
Financial performance
Product benchmarking
Latest strategic developments
Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance
A three-pronged approach was followed for deducing the catheter market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for catheter market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of catheter market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The catheter market was categorized into four segments, namely product type (Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, Specialty Catheters), distribution channel (Hospital Stores, Retail Stores), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).
The catheter market was segmented into product type, distribution channel, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The catheter market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK, Germany; France; Italy; Spain; Sweden; Denmark; Norway; Japan; China; India; South Korea; Thailand; Australia; Brazil; Mexico; Argentina; South Africa; UAE; Kuwait; Saudi Arabia.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The catheter market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
Medtronic- Medtronic is a global medical technology company. It operates through four business segments-diabetes, cardiac & vascular, restorative therapies, and minimally invasive therapies. These segments are subdivided into different divisions that deliver a broad range of therapies, solutions, services, and medical technologies. The company also provides products to treat chronic diseases. It has more than 4,600 patents. The company caters to customers through a network of partners and subsidiaries in 160 countries globally.
Edwards Lifesciences Corporation - Edward Lifesciences Corporation, a medical equipment company, operates in three major business segments- critical care, structural heart disease, and surgical monitoring. The company offers catheter products under the critical care business segment. It has manufacturing sites in several global locations, including North America, the Caribbean, Europe, and Singapore. Edwards supplies products and services to physicians in nearly 100 countries.
Smith Medical (Smith Group Plc.) - Smith Medical majorly manufactures, markets, and distributes specialist medical instruments that offer cutting-edge, life-saving technologies. Smiths Medical is a subsidiary of Smiths Group plc, a multinational technology company. Infusion Therapy, Vital Care, Vascular Access, and Specialty Products & Services are among the company's specialties. The company also manufactures drugs that are used to treat critical conditions. The Infusion Therapy segment majorly comprises fluid and opioid delivery systems for pain relief. The Vital Care segment majorly comprises devices for monitoring patients' airways and body temperature. The products for the advanced treatment fields of veterinary health, transport breathing, patient tracking, and medical equipment engineering are included under the specialty products & services segment. The firm operates in more than 50 countries around the world.
Boston Scientific Corporation - Boston Scientific Corporation develops and manufactures medical devices that are used in interventional medical specialties. The company’s products are marketed to approximately 35,000 medical offices, outpatient facilities, clinics, & hospitals in the U.S. and around 120 countries globally. The company operates through three segments- Cardiovascular, Rhythm Management, and MedSurg. The products offered for sale are through seven core businesses-electrophysiology, neuromodulation, urology & pelvic health, peripheral interventions, endoscopy, cardiac rhythm management, and interventional cardiology.
Hollister Incorporated - Hollister Incorporated develops, manufactures, and markets healthcare products and services. The company offers its products through four business segments-ostomy care, bowel care, continence care, and wound care & tube fasteners. It has manufacturing facilities in Kirksville, Missouri; Stuarts Draft, Virginia; Ballina, Ireland; Fredensborg, Denmark; Bawal, India; and Kaunas, Lithuania. The company also has distribution centers in Oud Gastel & Etten-Leur, the Netherlands, and Mt. Juliet, Tennessee. It provides its products and services through a network of partners and distributors.
Coloplast Corporation - Coloplast Corporation is a Danish manufacturing and marketing company. It has a distribution network spread across 53 countries. Its product range includes ostomy, urology, continence, wound care, and skin care. The company primarily supplies its products to hospitals, pharmacies, wholesalers, and institutions. The company caters to its products through a network of dealers in Canada, the U.S., and other international markets.
Company Overview - ConvaTec, Inc. is a global medical products company. Its product portfolio includes ostomy care, continence care, critical care, wound therapeutics, and infusion devices. It has manufacturing sites in 8 countries and a distribution network that spans over 100 countries. It also provides single-use medical equipment in the healthcare domain in Europe, Asia Pacific, and MEA. The company operates as a wholly owned subsidiary of ConvaTec Group.
Cure Medical LLC - Cure Medical LLC is a catheter manufacturing and distributing company. The company’s product line includes intermittent catheters and closed-system catheters. The company offers catheters for different therapeutic conditions such as multiple sclerosis, prostate cancer, spina bifida (a birth defect in the spine & spinal cord), spinal cord injury, and transverse myelitis (inflammation in the spinal cord)
Wellspect Healthcare - Wellspect HealthCare is a manufacturer of urology and surgical products. Its key offerings include hydrophilic catheters, blood management products, respiratory products, and wound drainage products for postoperative conditions. The company has a presence in more than 30 countries including Norway, Spain, Sweden, Austria, Belgium, the Netherlands, Denmark, Finland, the UK, and the U.S. This company operates as a wholly-owned subsidiary of DentsPly Sirona, Inc.
Manfred Sauer GmbH - Manfred Sauer GmbH manufactures medical supplies. It offers urinary sheaths, single-use catheters, urine collection bags, and other associated accessories. The company’s products are exported to other countries through a network of distributors. The company also supports medical trials by providing prototypes with special dip coating.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
revenue/volume
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."